Stay updated on CAB-AXL-ADC in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.

Latest updates to the CAB-AXL-ADC in Sarcoma Clinical Trial page
- Check3 days agoChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4, indicating a software/UI update. This change does not modify the study content.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe Taiwan site entry was updated from Taoyuan District, Taiwan to Taoyuan, Taiwan in the Locations section, aligning the listed site with a city-level designation.SummaryDifference0.0%

- Check25 days agoChange DetectedThe page’s footer reflects an update to the ClinicalTrials.gov site revision (moving from v3.5.2 to v3.5.3), indicating a platform/version change rather than an update to the trial record itself.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study details or page functionality are indicated by this update.SummaryDifference0.0%

- Check54 days agoChange DetectedMalignant fibrous histiocytoma is added as a related term, and the Genetic and Rare Diseases Information Center resources are now listed.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to CAB-AXL-ADC in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.